Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Clinical trial NCT02425644 · COMPLETED
Trial details
- NCT number
- NCT02425644
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2019-05-16
- Enrollment
- 1133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.